SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-18-000209
Filing Date
2018-08-10
Accepted
2018-08-09 17:59:23
Documents
23
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q skin0806form10q.htm 10-Q 116379
2 EXHIBIT 31.1 skin0806form10qexh31_1.htm EX-31.1 8327
3 EXHIBIT 31.2 skin0806form10qexh31_2.htm EX-31.2 8346
4 EXHIBIT 32.1 skin0806form10qexh32_1.htm EX-32.1 4326
  Complete submission text file 0001554795-18-000209.txt   504429

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE skin-20180630.xml EX-101.INS 25258
6 XBRL SCHEMA FILE skin-20180630.xsd EX-101.SCH 6490
7 XBRL CALCULATION FILE skin-20180630_cal.xml EX-101.CAL 15832
8 XBRL DEFINITION FILE skin-20180630_def.xml EX-101.DEF 4275
9 XBRL LABEL FILE skin-20180630_lab.xml EX-101.LAB 57306
10 XBRL PRESENTATION FILE skin-20180630_pre.xml EX-101.PRE 38826
Mailing Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN ST SALT LAKE CITY UT 84106 8013232395
SKINOVATION PHARMACEUTICAL INC (Filer) CIK: 0001118072 (see all company filings)

IRS No.: 870458170 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30991 | Film No.: 181006570
SIC: 6770 Blank Checks
Office of Real Estate & Construction